Symbiotec Pharmalab's ₹1,757 crore IPO opened for subscription on August 24, with a price band and key dates disclosed. Brokerages have issued positive views, citing the company's strong API portfolio growth, while grey market premiums are being tracked. The issue closes on August 28.
No articles in the last 24 hours. Expand to 1 week
